|
| Tuesday, 22 February 2011, 14:00 HKT/SGT | |
| |  | |
Source: A*STAR | |
|
|
|
|
| Current R&D success with A*STAR's IMRE prompts Nitto Denko to invest more in Singapore by building a prototyping centre, which will be incubated at local research institute. |
SINGAPORE, Feb 22, 2011 - (ACN Newswire) - Nitto Denko Asia Technical Centre (NAT) will be expanding its Singapore base to include a prototyping centre in Singapore. The centre will be pioneered at A*STAR's Institute of Materials Research and Engineering (IMRE) under a unique Lab-in-RI programme. NAT can leverage on existing infrastructure, research expertise, and save cost on facilities and equipment while working to establish the new prototyping centre.
The decision for the new centre stems from IMRE's successful R&D project with NAT on optical waveguide devices, which are cheaper to manufacture and are more sensitive. NAT now wants to explore the biosensing applications of these devices and put them into a new range of low-cost, easy-to-use, home-based, consumer biosensors.
"The optical waveguide devices that were developed will give us the opportunity to create version 2.0 biosensors for future homes", said Dr Su Xiaodi, a Senior Scientist who heads the IMRE research team. She will be working with NAT to put the devices into home-based biosensors that allow users to monitor their health with greater frequency and care, in the comfort of their home, and between visits to the doctor. The targeted users are those with health conditions that could change rapidly or require immediate attention.
"IMRE has been a credible partner since our initial collaboration in 2008, and we would like to continue to draw on IMRE's intellectual resources and excellent facilities to further our R&D activities in Singapore", said Dr Visit Thaveeprungsriporn, Director of NAT.
"The new sensor demonstrates how materials science research can benefit even the biomedical industry", said Prof Andy Hor, IMRE's Executive Director. "The setting up of the new prototyping lab in IMRE is a testament to our expertise and shows how industrially-relevant research institutes can be".
Nitto Denko is one of Japan's leading diversified materials manufacturer and a major producer of optical films used in LCD TVs. It invested S$10 million in setting up the Nitto Denko Asia Technical Centre (NAT) in Singapore to work on organic electronics research in 2008.
The IMRE-Nitto Denko team will begin R&D development at the new prototyping centre in February 2011 with a prototype expected to be available in early 2012.
About the Institute of Materials Research and Engineering (IMRE)
Established in September 1997, IMRE has built strong capabilities in materials analysis, characterisation, materials growth, patterning, fabrication, synthesis and integration. IMRE is an institute of talented researchers equipped with state-of-the-art facilities such as the SERC Nanofabrication and Characterisation Facility to conduct world-class materials science research. Leveraging on these capabilities, R&D programmes have been established in collaboration with industry partners. These include research on organic solar cells, nanocomposites, flexible organic light-emitting diodes (OLEDs), solid-state lighting, nanoimprinting, microfluidics and next generation atomic scale interconnect technology. For more information about IMRE, please visit www.imre.a-star.edu.sg.
Contact:
Ms Jofelyn Lye
Senior Officer, Corporate Communications
for Institute of Materials Research and Engineering (IMRE)
DID: +65 6874 8349
Mobile: +65 9647 2577
Email: lyejml@scei.a-star.edu.sg
Ms Juliana Chua
Sr. Business Analyst, Business Development
for Nitto Denko Asia Technical Centre (NAT)
Tel: +65 6467 7782
Email: juliana_chua@gg.nitto.co.jp
For technical, business and membership enquiries, please contact:
Dr Su Xiaodi
Senior Scientist
Institute of Materials Research and Engineering (IMRE)
DID: +65 6874 8420
Email: xd-su@imre.a-star.edu.sg
Mr Colin Leong
Industry Development Manager
Institute of Materials Research and Engineering (IMRE)
DID: +65 6872 7732
Email: colin-leong@imre.a-star.edu.sg
Topic: Establishment of New Branch
Source: A*STAR
Sectors: Science & Nanotech, Science & Research
http://www.acnnewswire.com
From the Asia Corporate News Network
Copyright © 2024 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
|
|
|
|
|
|
|
| A*STAR |
| Dec 6, 2022 14:00 HKT/SGT |
|
Global pharma giants partner Singapore researchers to boost innovation in biologics and vaccines manufacturing |
| June 2, 2022 21:00 HKT/SGT |
|
Boehringer Ingelheim Enters Global Licensing Agreement to Develop and Commercialize Innovative Antibodies from A*STAR for Targeted Cancer Therapies |
| June 2, 2022 21:00 HKT/SGT |
|
Boehringer Ingelheim Enters Global Licensing Agreement to Develop and Commercialize Innovative Antibodies from A*STAR for Targeted Cancer Therapies |
| Sept 30, 2021 16:00 HKT/SGT |
|
A*STAR and Local SME Work with Vaccination Centres to Deploy AVID System for Filling Syringes |
| July 31, 2020 08:00 HKT/SGT |
|
Singapore Cancer Drug ETC-159 Advances Further in Clinical Trials |
| July 24, 2020 17:00 HKT/SGT |
|
MP Biomedicals and A*STAR Co-Develop Rapid Antibody Test Kit for SARS-CoV-2 |
| Oct 22, 2019 04:00 HKT/SGT |
|
Fujitsu, SMU and A*STAR Launch Digital Platform Experimentation Project using Quantum-Inspired Computing and Deep Learning Technology |
| June 28, 2019 08:00 HKT/SGT |
|
Singapore's Drug Development Efforts Given Additional Momentum with National Platforms |
| Apr 5, 2019 18:00 HKT/SGT |
|
Passing of Dr Sydney Brenner, Nobel Laureate, Renowned Pioneer in Molecular Biology, A*Star Senior Fellow |
| Jan 21, 2019 13:00 HKT/SGT |
|
Branched-Chain Amino Acids Found to Regulate the Development and Progression of Cancer |
| More news >> |
 |
|
|
|
